Padmanee Sharma is a professor in the departments of Genitourinary Medical Oncology and Immunology, scientific director for the immunotherapy platform, and co-director of Parker Institute for Cancer Immunotherapy at MD Anderson Cancer Center. A trained medical oncologist and immunologist, her research work is focused on investigating mechanisms and pathways within the immune system that are responsible for tumor rejection and clinical benefit. She is the principal investigator of multiple immunotherapy clinical trials and conducts translational laboratory studies related to these trials. Sharma’s studies enable development of novel immunotherapy strategies for the treatment of cancer patients. She received the Emil Frei III Award for Excellence in Translational Research in 2016.
Previously
Whether the headlines describe a “cancer moonshot” or a “war on cancer,” they capture a yearning and determination to eliminate the scourge of malignancy. Artificial intellige...